ELEVATE-HFpEF Clinical Study
NCT: NCT06678841 · RECRUITING
NCT IDNCT06678841
StatusRECRUITING
Start Date2025-07-09
Completion2029-02
Brief Summary
ELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of dual chamber personalized pacing compared to minimal or no pacing for the treatment of patients with heart failure with preserved ejection fraction (HFpEF).
Frequently Asked Questions
What is ELEVATE-HFpEF Clinical Study?
ELEVATE-HFpEF Clinical Study is a clinical trial registered under NCT06678841. Current status: RECRUITING.
What is the status of NCT06678841?
The current status of NCT06678841 (ELEVATE-HFpEF Clinical Study) is: RECRUITING.
When did ELEVATE-HFpEF Clinical Study start?
ELEVATE-HFpEF Clinical Study started on 2025-07-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.